3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER_GOV
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Carcinoma, Non-Small-Cell Lung
135
Small Cell Lung Carcinoma
51
Lung Neoplasms
45
Melanoma
15
Carcinoma, Renal Cell
14
Carcinoma, Transitional Cell
10
Stomach Neoplasms
9
Neoplasms
9
Head and Neck Neoplasms
9
Carcinoma, Hepatocellular
9
Mesothelioma, Malignant
8
Colorectal Neoplasms
8
Urinary Bladder Neoplasms
7
Triple Negative Breast Neoplasms
7
Squamous Cell Carcinoma of Head and Neck
6
Breast Neoplasms
6
Uterine Cervical Neoplasms
5
Neoplasm Metastasis
5
Kidney Neoplasms
5
Carcinoma, Merkel Cell
5
Thoracic Neoplasms
4
Carcinoma, Neuroendocrine
4
Small Cell Lung Cancer Extensive Stage
3
Pancreatic Neoplasms
3
Ovarian Neoplasms
3
Mesothelioma
3
Lung Diseases
3
Gastrointestinal Neoplasms
3
Esophageal Neoplasms
3
Brain Neoplasms
3
Interventions
pembrolizumab
44
Carboplatin
17
Pemetrexed
14
Paclitaxel
13
Cisplatin
13
lenvatinib
5
Etoposide
5
Docetaxel
5
epacadostat
4
Gemcitabine
4
Albumin-Bound Paclitaxel
4
durvalumab
3
Nivolumab
3
130-nm albumin-bound paclitaxel
3
spartalizumab
2
olaparib
2
Saline Solution
2
Immune Checkpoint Inhibitors
2
Dexamethasone
2
Acetaminophen
2
sacituzumab govitecan
1
ribociclib
1
patritumab deruxtecan
1
osimertinib
1
etoposide phosphate
1
efineptakin alfa
1
cemiplimab
1
camrelizumab
1
avelumab
1
atezolizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Parkinson Disease 4, Autosomal Dominant Lewy Body
×
atezolizumab
×
Thoracic
×
Clear all
NCT07192926
2026-02-20
SARCO-CTI
Ankara Etlik City Hospital
Completed
131 enrolled